SCHEMBL17690385

SCHEMBL17690385

c1ccc(N(c2ccccc2)c2ccc(-c3cccc4cccc(-c5ccc(-c6nc7ccccc7n6-c6ccccc6)cc5)c34)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.49
ESR2 Q92731 2/20 0.49
RECQL P46063 1/20 0.46
GRIA1 P42261 1/20 0.45
CACNG8 Q8WXS5 1/20 0.45
CACNG2 Q9Y698 1/20 0.45
HTT P42858 3/20 0.43
MAPK1 P28482 1/20 0.43
SIRT2 Q8IXJ6 2/20 0.42
SIRT1 Q96EB6 2/20 0.42
PTGS2 P35354 1/20 0.41
RAB9A P51151 4/20 0.41
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 3/20 0.41
MAPT P10636 3/20 0.41
HPGD P15428 3/20 0.41
NPC1 O15118 2/20 0.41
GFER P55789 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16692175 0.91 ESR1 (0.57) ESR1ESR2RECQLGRIA1CACNG8
SCHEMBL14330699 0.89 ESR1 (0.48) ESR1ESR2RECQLGRIA1CACNG8
SCHEMBL17038505 0.89 ESR1 (0.60) ESR1ESR2RECQLGRIA1CACNG8
SCHEMBL14330707 0.89 ESR1 (0.60) ESR1ESR2RECQLGRIA1CACNG8
SCHEMBL13133843 0.89 ESR1 (0.60) ESR1ESR2RECQLGRIA1CACNG8
SCHEMBL12205155 0.87 ESR1 (0.58) ESR1ESR2RECQLGRIA1CACNG8
SCHEMBL10047617 0.87 ESR1 (0.58) ESR1ESR2RECQLGRIA1CACNG8
SCHEMBL14330708 0.87 ESR1 (0.58) ESR1ESR2RECQLGRIA1CACNG8
SCHEMBL1451794 0.87 ESR1 (0.58) ESR1ESR2RECQLGRIA1CACNG8
SCHEMBL21757948 0.87 ESR1 (0.61) ESR1ESR2RECQLGRIA1CACNG8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10892419-B2 Space-through charge transfer compound, and organic light emitting diode and display device using the same LG DISPLAY CO., LTD. (KR) 2021-01-12 US disclosed
US-20190081244-A1 Space-Through Charge Transfer Compound, and Organic Light Emitting Diode and Display Device Using the Same LG DISPLAY CO., LTD. (KR) 2019-03-14 US disclosed
EP-3010064-B1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG DISPLAY CO LTD (KR) 2017-07-19 EP disclosed
US-20160111650-A1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2016-04-21 US disclosed
US-20160111650-A1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2016-04-21 US disclosed
EP-3010064-A1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG Display Co., Ltd. (KR) 2016-04-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10892419-B2 Space-through charge transfer compound, and organic light emitting diode and display device using the same NLRP1, NLRP3, CYBA ESR1 953/4885ESR2 3109/4885RECQL 2868/4885
US-20160111650-A1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME NLRP1, NLRP3, CYBA ESR1 953/4885ESR2 3109/4885RECQL 2868/4885
US-20190081244-A1 Space-Through Charge Transfer Compound, and Organic Light Emitting Diode and Display Device Using the Same NLRP1, NLRP3, CYBA ESR1 953/4885ESR2 3109/4885RECQL 2868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.